- Press Release Distribution

BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy

BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy

This study is led by Professor Junnian Zheng and Ming Shi from the Cancer Institute of Xuzhou Medical University, together with the team of Professor Guiyun Cui and Wei Zhang from the Affiliated Hospital of Xuzhou Medical University. The team reported for the first time using BCMA-CD19 bispecific CAR T cells for treating relapsed/refractory CIDP.


Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is an uncommon condition with sudden onset symptoms, including nerve damage affecting movement, sensation, speech, breathing, and heart rate. Over 80% of people develop muscle weakness, impaired gait, absent tendon reflexes, sensory loss, balance problems, and, in severe cases, paralysis, irregular heart rhythm, and difficulty breathing. Currently, treatments such as glucocorticoids, plasma exchange, and intravenous gamma globulin (IVIg) can help manage symptoms but cannot completely eradicate the disease.


In recent years, chimeric antigen receptor (CAR)-T cell therapy has achieved remarkable efficacy in hematologic tumors and many diseases represented by systemic lupus erythematosus. The team reported using BCMA-CD19 bispecific CAR T cells for treating relapsed/refractory CIDP.


B cell clearance coupled with anti-CD20 antibody has been used to treat CIDP. However, CD20 and CD19 are mainly found during earlier stages of B cell development and do not appear on long-lived plasma cells. Taking advantage of the BCMA protein's presence in plasma blasts and long-lived plasma cells, researchers at Xuzhou Medical University designed bispecific CAR-T cells that target both CD19 and BCMA, aiming to reset the balance of immune responses by temporarily and deeply eradicating B cells and plasma cells.


A 44-year-old man with relapsed/refractory CIDP exhibited distal limb numbness and weakness. Following the 2021 European Society of Neurology/Society of Peripheral Neurology CIDP Guidelines, he was diagnosed with distal CIDP without IgG4 autoantibodies. Post-admission evaluation and discussion led to his eligibility for bispecific CAR-T therapy for autoimmune disease, which he successfully underwent.


Following CAR-T cell therapy, the patient has made significant progress in functioning as per INCAT disability and MRC scores. Remarkably, almost full muscle power recovery was observed 180 days after CAR-T administration, paralleling his ability to walk again.  Initially, it took them 21 seconds to cover a 10-meter walk, but by day 180, they managed it in just 13 seconds.  Post-treatment electrophysiological assessments of median, ulnar, common peroneal, and tibial nerves showed significant improvement.  After the initial 180-day follow-up, we checked in with them every 90 days to monitor any potential relapse.  Remarkably, for more than a year, this patient could discontinue all immunosuppressants without disease recurrence, and the presence of GM4 and GD3 antibodies continued to diminish even after 3 months of CAR-T cell therapy.


Regarding safety, patients developed fever (38-39°C) and transient IL-6 elevation 6-14 days after CAR-T cell therapy and were treated symptomatic with acetaminophen. The patient developed hypotension (86-97/35-59 mmHg, grade 2) 1-15 days after CAR T cell infusion and recovered after 2 weeks of bed rest and plenty of water. No other toxicity associated with CAR-T cell therapy was observed.


This case shows how viable, well-tolerated, and effective BCMA-CD19 bispecific CAR T cells are for treating stubborn/repetitive CIDP. Even without continued immunosuppressants, remission stayed put despite B cell levels rising again. Also, it has the potential to help those suffering from autoimmune nerve disorders linked to B cells, such as neuromyelitis and myasthenia gravis.


This study highlights the change in patient symptoms after treatment and affirms the safety of CAR-T cell therapy for CID. While a single case report, more extensive studies, and extended follow-up, which is on the way, would add significant clinical value. It highlights the potential of CAR-T cell therapy in treating relapsed/refractory autoimmune disorders. This "dual-target" strategy is a promising step toward creating a potentially curable treatment for CIDP.


See the article:

Zhang W, Liu D, Zhang T, et al. BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy. hLife.


[Attachments] See images for this press release:
BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy 2 BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy 3


Embryo and organoid models do not threaten the definition of personhood, bioethicist says

Advances in organoids and embryonic models of human development have the potential to prompt social and existential questions—e.g., what defines human individuality? However, bioethicist Insoo Hyun of Harvard Medical School and the Museum of Science in Boston says that these models have the potential to strengthen rather than weaken the concept of human individuality when considered within the philosophical frameworks of “personhood” and sentience. In a commentary publishing June 20 in the journal Cell, Hyun argues that despite huge advances, we are a long way off from developing technologies that would ...

Great British Bake Off finalist Josh Smalley discusses the parallels between chemistry and baking

Great British Bake Off finalist Josh Smalley discusses the parallels between chemistry and baking
Last year on a Friday evening, chemical biology researcher Josh Smalley was in the lab when he received a call inviting him to appear on the 14th and latest season of The Great British Bake Off. Starting as one of a group of 12 amateur bakers, Smalley made it all the way to the final round, where the top 3 contestants compete for the winning spot. In an essay published in the journal Cell Chemical Biology on June 20, Smalley describes the overlap between chemistry and baking and how his training in one ...

New genetic cause of obesity could help guide treatment

Scientists have discovered a new cause of why people who lack a specific blood group are genetically predisposed to be overweight or obese. A team of international researchers, led by the University of Exeter, discovered that people with a genetic variant that disables the SMIM1 gene have higher body weight because they expend less energy when at rest. SMIM1 was only identified 10 years ago, whilst searching  for the gene encoding a specific blood group, known as Vel. One in 5,000 people  lack both copies of the gene, making them Vel-negative. The findings from the new research suggest that this group is also more likely to be overweight, a conclusion ...

Palaeontology: New, small, ancient crocodile-like reptile described in Brazil

The discovery of a new, ancient, predatory reptile dubbed Parvosuchus aurelioi — part of a group of crocodile-like reptiles called pseudosuchians — in Brazil is described in a paper in Scientific Reports. The specimen, which dates to approximately 237 million years ago, during the Middle-Late Triassic, is the first small predatory reptile of its kind to be found in this country. Prior to the dominance of the dinosaurs, pseudosuchians were a common form of ancient quadruped reptile during the Triassic Period (252 – 201 million years ago), with some species amongst ...

Prenatal maternal psychological distress during the pandemic and newborn brain development

About The Study: The findings of this study suggest that increased maternal mental health symptoms during the COVID-19 pandemic are associated with subsequent changes in regional brain growth in newborn offspring.  Corresponding Author: To contact the corresponding author, Nickie Andescavage, M.D., email To access the embargoed study: Visit our For The Media website at this link (doi:10.1001/jamanetworkopen.2024.17924) Editor’s Note: Please see the article for additional information, including ...

Healthy lifestyle and the likelihood of becoming a centenarian

About The Study: In this case-control study of Chinese older adults, adhering to a healthy lifestyle appears to be important even at late ages, suggesting that constructing strategic plans to improve lifestyle behaviors among all older adults may play a key role in promoting healthy aging and longevity.  Corresponding Authors: To contact the corresponding authors, email Xiang Gao, M.D., Ph.D. ( and Xiaoming Shi, M.D., Ph.D. ( To access the embargoed study: Visit our For The Media website at this link (doi:10.1001/jamanetworkopen.2024.17931) Editor’s Note: Please see ...

New, simple test detects rare fatal genetic heart condition

A team of international researchers has revealed a new, simple clinical test to detect Calcium Release Deficiency Syndrome (CRDS), a life-threatening genetic arrhythmia that causes dangerously fast heartbeats and can lead to severe complications such as sudden cardiac arrest and death. The new diagnostic method monitors for changes in electrocardiography (ECG) after a brief period of a fast heartbeat and a pause, which can occur naturally or be induced by artificially pacing the heart. This research was co-led by Jason Roberts, a scientist at the Population ...

YALE NEWS: Chemotherapy before surgery benefits some patients with pancreatic cancer

New Haven, Conn. — Patients with pancreatic cancer who received chemotherapy both before and after surgery experienced longer survival rates than would be expected from surgery followed by chemotherapy, according to a new study from researchers at Yale Cancer Center (YCC) and Yale School of Medicine. The study, published June 20 in JAMA Oncology, included patients with pancreatic ductal adenocarcinoma (PDAC), which accounts for 90% of pancreatic cancers. An aggressive cancer with a high mortality rate, PDAC is predicted ...

First conclusive evidence that a terrestrial leech species can jump

First conclusive evidence that a terrestrial leech species can jump
A new study presents video evidence that at least one species of terrestrial leech can jump, behavior that scientists have debated for more than a century. Researchers from the American Museum of Natural History, Fordham University, and City University of New York (CUNY)’s Medgar Evers College published the footage and corresponding analysis today in the journal Biotropica. “We believe this is the first convincing evidence that leeches can jump and do so with visible energy expenditure,” said lead author Mai Fahmy, a visiting scientist at the Museum and a postdoctoral researcher ...

Creation of a power-generating, gel electret-based device

Creation of a power-generating, gel electret-based device
1. A team of researchers from NIMS, Hokkaido University and Meiji Pharmaceutical University has developed a gel electret capable of stably retaining a large electrostatic charge. The team then combined this gel with highly flexible electrodes to create a sensor capable of perceiving low-frequency vibrations (e.g., vibrations generated by human motion) and converting them into output voltage signals. This device may potentially be used as a wearable healthcare sensor. 2. Interest in the development of soft, lightweight, power-generating materials has been growing in recent years for use in soft electronics designed for various purposes, such as ...


Expanding APAC presence, Insilico Medicine seals strategic collaboration on AI-driven mash therapy development with Korean Biotech Therasid Bioscience

When it comes to butterflies, people prefer pretty ones. That’s a problem for scientists.

UBC Okanagan study raises concerns about partner violence in queer relationships

Human-infecting parasite produces sterile soldiers like ants and termites

The unintended consequences of success against malaria

Taco-shaped arthropod from Royal Ontario Museum’s Burgess Shale fossils gives new insights into the history of the first mandibulates

Butterflies accumulate enough static electricity to attract pollen without contact, new research finds

Eyes for Love: Searching for light and a mate in the deep, dark sea, male dragonfishes grow larger eyes than the females they seek

PNNL scientists tap nation’s fastest computers to explore critical science questions

Peri-operative care of transgender and gender-diverse individuals: new guidance for clinicians and departments published

Clinical psychologist’s book addresses largely ignored problem: social anxiety

Researchers leveraging AI to train (robotic) dogs to respond to their masters

Drawing water from dry air

Combining trapped atoms and photonics for new quantum devices

A new way to make element 116 opens the door to heavier atoms

New genetic tool could identify drug targets for diseases associated with metabolic dysfunction

Plant Biologist Siobhan Brady named HHMI Investigator

Long-acting injectable cabotegravir for HIV prevention is safe in pregnancy

Large language models don’t behave like people, even though we may expect them to

NREL researchers highlight opportunities for manufacturing perovskite solar panels with a long-term vision

Top Medicare advantage plans less available in disadvantaged areas

Better carbon storage better carbon storage with stacked geology with stacked geology

Sharp temperature reduction for quantum dots in polymer by highly efficient heat dissipation pathways

UAF researcher creates way to detect elusive volcanic vibrations

Lissajous pattern multi-pass cell: Enhancing high sensitivity and simultaneous dual-gas LITES sensing

Asexual reproduction usually leads to a lack of genetic diversity. Not for these ants.

Mini lungs make major COVID-19 discoveries possible

Exploratory analysis associates HIV drug abacavir with elevated cardiovascular disease risk in large global trial

Control of light–matter interactions in two-dimensional materials with nanoparticle-on-mirror structures

Does the onset of daylight saving time lead to an unhealthy lifestyle?

[] BCMA-CD19 bispecific CAR-T therapy in refractory chronic inflammatory demyelinating polyneuropathy